Featured News

If you have unexplained symptoms or have a family member with celiac disease, complete the Symptoms Assessment Tool to see if you have an increased risk for celiac disease and receive a free product from Proud Sponsor Schar.

Researchers found that roughly one-third of celiac patients reported using probiotics for perceived health benefits, despite the lack of evidence that probiotics are an effective treatment for celiac disease symptoms.

Please take one minute to email your Members of Congress to make it easier and safer for those with celiac disease to purchase food items by requiring labels to list the presence of barley and rye, in addition to wheat.

Please take ONE MINUTE to contact your Members of Congress, using our simple, pre-populated form, to make it easier and safer for individuals with celiac disease by disclosing if foods contain rye and barley, in addition to wheat.

There are more exciting opportunities than ever before to participate in celiac disease clinical trials. Researchers are making groundbreaking progress in the race for better treatments with promising new drug candidates.

The FDA hosted the Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics VI (GREAT VI) Workshop on Celiac Disease - the second workshop ever held by the FDA for celiac disease.

Thank you to everyone who participated in the CDF Bid for a Cure Online Auction! All money raised will directly accelerate celiac disease research.

Researchers at Boston Children’s Hospital are evaluating access to gluten-free food prior to and during the COVID-19 pandemic. We invite anyone with celiac disease following a gluten-free diet to complete this 3-5 minute survey.

Join the Schär team for their first ever 3-part School Nutrition Webinar Series on managing celiac disease and other dietary restrictions in learning environments! Register for free for all 3 days and be eligible for CEUs and a Schär giveaway!

Periodically, the FDA hosts workshops to help researchers understand exactly what the FDA will be looking for (aka “endpoints”) when evaluating the efficacy of a proposed drug.